Aprinoia Therapeutics

View the org chart displaying its 9 main executives

Most searched biographies at Aprinoia Therapeutics

• Mark Shearman, Chief Executive Officer
• Ming-Kuei Jang, Chairman of the Board
• Lili Zhang, Senior Vice President and Head of Preclinical Developm...

Create your alert
to follow the executive moves at Aprinoia Therapeutics.

Aprinoia Therapeutics has 2,293 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Merck has announced the acquisition of EyeBio  (posted on May 31 2024).
• Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Aprinoia Therapeutics

Social media about Aprinoia Therapeutics

• Aprinoia Therapeutics on Wikipedia, Google News & Yahoo Finance
• Aprinoia Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Mark Shearman

Call Aprinoia Therapeutics at +86 886 ...

View the org chart

Register to receive your alert

Report an error